Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Express Scripts
Argus Health
Dow
Healthtrust
Cantor Fitzgerald
Federal Trade Commission
Boehringer Ingelheim
Chubb

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206302

« Back to Dashboard

NDA 206302 describes BYVALSON, which is a drug marketed by Allergan Sales Llc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the BYVALSON profile page.

The generic ingredient in BYVALSON is nebivolol hydrochloride; valsartan. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nebivolol hydrochloride; valsartan profile page.
Summary for 206302
Tradename:BYVALSON
Applicant:Allergan Sales Llc
Ingredient:nebivolol hydrochloride; valsartan
Patents:2
Formulation / Manufacturing:see details
Pharmacology for NDA: 206302
Suppliers and Packaging for NDA: 206302
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BYVALSON nebivolol hydrochloride; valsartan TABLET;ORAL 206302 NDA Allergan, Inc 0023-5874 N 0023-5874-30
BYVALSON nebivolol hydrochloride; valsartan TABLET;ORAL 206302 NDA Allergan, Inc 0023-5874 N 0023-5874-32

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE;80MG
Approval Date:Jun 3, 2016TE:RLD:Yes
Regulatory Exclusivity Expiration:Jun 3, 2019
Regulatory Exclusivity Use:NEW COMBINATION
Patent:➤ Sign UpPatent Expiration:Aug 29, 2026Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Oct 4, 2027Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD OF TREATING HYPERTENSION

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Colorcon
Fish and Richardson
Fuji
Mallinckrodt
Merck
Cantor Fitzgerald
Farmers Insurance
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.